Pepdox
Studies
Peptides
Calculator
In adults with overweight or obesity, weekly subcutaneous cagrilintide-semaglutide increased weight loss at 68 wk. | Pepdox
Home
/
Search
/
PMID 41052437
In adults with overweight or obesity, weekly subcutaneous cagrilintide-semaglutide increased weight loss at 68 wk.
Annals of internal medicine
2025
PMID: 41052437
View on PubMed
DOI: 10.7326/ANNALS-25-03745-JC
Semaglutide
Abstract
GIM/FP/GP: [Formula: see text].
Authors
Agarwal, Arnav; Padwal, Raj